Skip to main content
spacbrain

EUDA Health Holdings

Closed (deSPAC)

Health Care · digital healthcare ecosystem platform

What it is
Health Limited EUDA Health Limited is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, and improving the patient experience by delivering better outcomes through personalized healthcare
What it’s doing now
Merging with 8i Acquisition 2 Corp. (LAX) — closed (despac).
What you should know
Data is still being assembled for this company — what is shown below is everything we have verified so far.

The business, per its filings

SEC primary

Health Limited EUDA Health Limited is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, and improving the patient experience by delivering better outcomes through personalized healthcare. The company’s proprietary unified AI platform quickly assesses a patient’s medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. EUDA Health’s holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. About 8i Acquisition 2 Corp. 8i Acquisition 2 Corp. is a British Virgin Islands company incorporated in January 2021 as a blank check company for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.

Source: DEFM14A, accession 0001493152-22-028312

What the company says about itself

Web research — not audited

EUDA Health Holdings Ltd. aims to become a market leader in non-invasive and preventive healthcare, focusing on the longevity sector. Its mission is to address the healthcare needs of over 1.8 billion people across Southeast Asia and China, offering science-backed health solutions to shift regional healthcare from reactive treatment to proactive, longevity-focused care.

Markets:
Non-invasive and preventive healthcare | Longevity sector
Products:
EUDA Helixé Nutragenic Supplement | Bioenergy Capsule | Stem Cell Therapy | CRISPR - Gene Editing
What our web check found

[WEB-INTEL 2026-08-26] 2 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "EUDA Health Holdings Limited has filed a resale prospectus covering up to 947,963 ordinary shares, including 7,306 shares ,250 warrants." [https://www.stocktitan.net/sec-filings/EUDA/424b3-euda-health-holdings-ltd-prospectus-filed-pursuant-to-rule-424--8114829a6b18.html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "$172 million by issuing 14 million new LAX ordinary shares for 100% of EUDA Health of up to 4 million LAX ordinary shares before December 31, 2024." [https://www.8icorp.com/en/author/8eac/]

Source: https://eudahealth.com/ · captured Aug 26, 2026 · marketing claims are reported as claims, never merged into the filed figures above.

The deal it’s entering

EUDA Health Holdings is merging with 8i Acquisition 2 Corp. (LAX) currently marked Closed (deSPAC).

Headline equity value—

How to read these numbers: headline vs effective valuation · what a definitive agreement commits

What exactly is being valued, and at what

Common questions

Is EUDA Health Holdings going public?

EUDA Health Holdings has an approved merger with the SPAC 8i Acquisition 2 Corp. (LAX). Deal status: Closed (deSPAC).

Does EUDA Health Holdings have revenue?

The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.

Educational content, not investment advice.

Other health care deals